COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
MindBio Therapeutics Receives Final Regulatory Approval to Conduct Phase 2B Randomised Controlled Trial Microdosing Mb22001 in Patients Diagnosed with Major Depressive Disorder
Ethics and regulatory approvals finalized for world-first take-home use of psychedelic medicine MB22001 in Phase 2B randomized controlled trial for Major Depressive Disorder by MindBio Therapeutics Corp -
COMMUNIQUÉ DE PRESSE
Original-Research: Alzchem Group AG (von Sphene Capital GmbH): Buy
Alzchem Group AG erhält Buy-Einstufung und Kursziel von EUR 43,40 durch Sphene Capital GmbH nach profitabler Jahresbilanz. Erfolgreiche Quartalsergebnisse und Strategien sorgen für positives Wachstum. Vollständige Analyse zum Download verfügbar -
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Media and Games Invest SE (von GBC AG): BUY
Media and Games Invest SE reports solid sales growth in FY 2023, with revenue reaching €321.98 million. The company outperforms the market, expecting double-digit growth in 2024. Price target raised to €4.50. Analysts recommend buying -
COMMUNIQUÉ DE PRESSE
Commerce Resources Announces Significant Advancements and Simplification of the Ashram Deposit’s Process Flowsheet
Commerce Resources Corp. announces advancements in mineral processing and hydrometallurgical flowsheets for the Ashram Rare Earth and Fluorspar Deposit in Quebec, Canada -
-
